Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Procter and Gamble releases Asacol tablets

Procter and Gamble releases Asacol tablets

9th July 2009

Procter & Gamble has announced the availability of Asacol HD (mesalamine) tablets, a delayed-release treatment for moderately active ulcerative colitis (UC).

UC is a variety of inflammatory bowel disease and involved irritation of the linings of the colon and rectum.

Typically characterised by flares that are punctuated by periods of remission, moderately active UC tends to feature symptoms that are “tougher” than the mildly active version of the condition, Procter & Gamble notes.

Dr Stephen Hanauer, chief of gastroenterology, hepatology and nutrition at the University of Chicago Medical Centre, said that in six-week clinical trials of moderately active UC, Asacol aided in the reduction of rectal bleeding and stool frequency.

This was achieved without the use of steroids, he added. “These encouraging results help support Asacol HD as an effective therapy in patients with moderately active UC.”

Last month, Procter & Gamble announced that its global external relations officer Charlotte Otto will retire in February 2010.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.